WT1 gene silencing by aerosol delivery of PEI–RNAi complexes inhibits B16-F10 lung metastases growth

[1]  K. Wagner,et al.  The Wilms' tumour suppressor WT1 is involved in endothelial cell proliferation and migration: expression in tumour vessels in vivo , 2008, Oncogene.

[2]  P. Diot,et al.  Aerodynamical, Immunological and Pharmacological Properties of the Anticancer Antibody Cetuximab Following Nebulization , 2008, Pharmaceutical Research.

[3]  Y. Oji,et al.  Wilms' tumor gene WT1-shRNA as a potent apoptosis-inducing agent for solid tumors. , 2008, International journal of oncology.

[4]  C. Cho,et al.  Urocanic acid-modified chitosan-mediated PTEN delivery via aerosol suppressed lung tumorigenesis in K-rasLA1 mice , 2008, Cancer Gene Therapy.

[5]  K. Wagner,et al.  The Wilms’ tumor suppressor WT1 is associated with melanoma proliferation , 2008, Pflügers Archiv - European Journal of Physiology.

[6]  M. Franco-Molina,et al.  RNAi silencing of the WT1 gene inhibits cell proliferation and induces apoptosis in the B16F10 murine melanoma cell line , 2007, Melanoma research.

[7]  P. Graidist,et al.  Growth inhibition of breast cancer cell line MCF-7 by siRNA silencing of Wilms tumor 1 gene. , 2007, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.

[8]  L. Bergmann,et al.  Effective treatment of leukemic cell lines with wt1 siRNA , 2007, Leukemia.

[9]  Jun Wang,et al.  [Study of growth inhibition of lung cancer cells by siRNA targeting mutant K-ras gene in vitro and in vivo]. , 2007, Zhonghua wai ke za zhi [Chinese journal of surgery].

[10]  Huiling Shen,et al.  Down-regulation of WT1/+17AA gene expression using RNAi and modulating leukemia cell chemotherapy resistance , 2007, Haematologica.

[11]  R. Perez-soler,et al.  p53 Aerosol Formulation with Low Toxicity and High Efficiency for Early Lung Cancer Treatment , 2007, Clinical Cancer Research.

[12]  Min-jian Kong,et al.  Down‐regulation of IGF‐IR using small, interfering, hairpin RNA (siRNA) inhibits growth of human lung cancer cell line A549 in vitro and in nude mice , 2007, Cell biology international.

[13]  G. Peters,et al.  Phase I Study of Aerosolized SLIT Cisplatin in the Treatment of Patients with Carcinoma of the Lung , 2007, Clinical Cancer Research.

[14]  M. Minden,et al.  A tumor suppressor and oncogene: the WT1 story , 2007, Leukemia.

[15]  M. Kris,et al.  Phase I Study of Inhaled Doxorubicin for Patients with Metastatic Tumors to the Lungs , 2007, Clinical Cancer Research.

[16]  W. Broaddus,et al.  Down-regulation of Wilms’ tumor 1 expression in glioblastoma cells increases radiosensitivity independently of p53 , 2007, Journal of Neuro-Oncology.

[17]  Peter Hohenstein,et al.  The many facets of the Wilms' tumour gene, WT1. , 2006, Human molecular genetics.

[18]  R. Löbenberg,et al.  Formulation and cytotoxicity of doxorubicin nanoparticles carried by dry powder aerosol particles. , 2006, International journal of pharmaceutics.

[19]  M. Ruan,et al.  High WT1 Expression Is Associated with Very Poor Survival of Patients with Osteogenic Sarcoma Metastasis , 2006, Clinical Cancer Research.

[20]  D. Loeb.  WT1 Influences Apoptosis Through Transcriptional Regulation of Bcl-2 Family Members , 2006, Cell cycle.

[21]  A. Geater,et al.  WT1 gene expression as a prognostic marker in advanced serous epithelial ovarian carcinoma: an immunohistochemical study , 2006, BMC Cancer.

[22]  E. Kleinerman,et al.  Intranasal interleukin‐12 gene therapy enhanced the activity of ifosfamide against osteosarcoma lung metastases , 2006, Cancer.

[23]  J. Licht,et al.  WT1 induces apoptosis through transcriptional regulation of the proapoptotic Bcl-2 family member Bak. , 2005, Cancer research.

[24]  W. Hiddemann,et al.  Prognostic impact of RT-PCR-based quantification of WT1 gene expression during MRD monitoring of acute myeloid leukemia , 2005, Leukemia.

[25]  K. Wagner,et al.  The complex life of WT1 , 2003, Journal of Cell Science.

[26]  L. Frati,et al.  Survivin, bcl-2, bax, and bcl-X gene expression in sentinel lymph nodes from melanoma patients. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[27]  L. Ellisen.  Regulation of Gene Expression by WT1 in Development and Tumorigenesis , 2002, International journal of hematology.

[28]  Musaffe Tuna,et al.  Downregulation of Wilms' tumor 1 protein inhibits breast cancer proliferation. , 2002, Biochemical and biophysical research communications.

[29]  S. Miyoshi,et al.  Overexpression of the Wilms' tumor gene WT1 in de novo lung cancers , 2002, International journal of cancer.

[30]  B. Ramsey,et al.  Pharmacokinetics and bioavailability of aerosolized tobramycin in cystic fibrosis. , 2002, Chest.

[31]  X. Tian,et al.  WT1 downregulation during K562 cell differentiation and apoptosis induced by bufalin. , 2002, Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi.

[32]  Y. Miyoshi,et al.  High expression of Wilms' tumor suppressor gene predicts poor prognosis in breast cancer patients. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[33]  A. Gautam,et al.  Gene delivery to the lung using protein/polyethylenimine/plasmid complexes , 2002, Gene Therapy.

[34]  E. Kleinerman,et al.  Eradication of osteosarcoma lung metastases following intranasal interleukin-12 gene therapy using a nonviral polyethylenimine vector , 2002, Cancer Gene Therapy.

[35]  U. Maurer,et al.  Ribozyme-mediated cleavage of wt1 transcripts suppresses growth of leukemia cells. , 2001, Experimental hematology.

[36]  R. Herrmann,et al.  Adenovirus-mediated wild-type p53 gene transfer in patients receiving chemotherapy for advanced non-small-cell lung cancer: results of a multicenter phase II study. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[37]  C. Densmore,et al.  Pulmonary cytokine responses associated with PEI–DNA aerosol gene therapy , 2001, Gene Therapy.

[38]  C. Densmore,et al.  Inhibition of experimental lung metastasis by aerosol delivery of PEI-p53 complexes. , 2000, Molecular therapy : the journal of the American Society of Gene Therapy.

[39]  M. Conese,et al.  Biodistribution and transgene expression with nonviral cationic vector/DNA complexes in the lungs , 2000, Gene Therapy.

[40]  K. Skubitz,et al.  Inhalational interleukin-2 liposomes for pulmonary metastases: a phase I clinical trial , 2000, Anti-cancer drugs.

[41]  A. Gautam,et al.  Enhanced gene expression in mouse lung after PEI-DNA aerosol delivery. , 2000, Molecular therapy : the journal of the American Society of Gene Therapy.

[42]  E. Bertelmann,et al.  Wilms' tumor gene (WT1) expression in lung cancer, colon cancer and glioblastoma cell lines compared to freshly isolated tumor specimens , 2000, Journal of Cancer Research and Clinical Oncology.

[43]  B. Kinsey,et al.  Aerosol delivery of robust polyethyleneimine-DNA complexes for gene therapy and genetic immunization. , 2000, Molecular therapy : the journal of the American Society of Gene Therapy.

[44]  A. Boletta,et al.  Comparison between cationic polymers and lipids in mediating systemic gene delivery to the lungs , 1999, Gene Therapy.

[45]  J. Sloan,et al.  Aerosol granulocyte macrophage-colony stimulating factor: a low toxicity, lung-specific biological therapy in patients with lung metastases. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[46]  C. Y. Wang,et al.  WT1 modulates apoptosis by transcriptionally upregulating the bcl‐2 proto‐oncogene , 1999, The EMBO journal.

[47]  D. Lubahn,et al.  Hypermethylation of the Wilms' tumor suppressor gene CpG island in human breast carcinomas , 1999, Breast Cancer Research and Treatment.

[48]  Y. Oji,et al.  Expression of the Wilms' Tumor Gene WT1 in Solid Tumors and Its Involvement in Tumor Cell Growth , 1999, Japanese journal of cancer research : Gann.

[49]  P. Diot,et al.  Aerosolized chemotherapy. , 2008, Journal of aerosol medicine and pulmonary drug delivery.

[50]  J. Roth,et al.  Cancer targeting using tumor suppressor genes. , 2008, Frontiers in bioscience : a journal and virtual library.

[51]  G. Fraizer,et al.  Regulation of vascular endothelial growth factor, VEGF, gene promoter by the tumor suppressor, WT1. , 2007, Frontiers in bioscience : a journal and virtual library.

[52]  S. Miyoshi,et al.  Absence of mutations in the Wilms' tumor gene wt1 in de novo non-small cell lung cancers. , 2004, Neoplasma.

[53]  J. Gu,et al.  Induction of p53-regulated genes and tumor regression in lung cancer patients after intratumoral delivery of adenoviral p53 (INGN 201) and radiation therapy. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[54]  C. Densmore,et al.  Aerosol delivery of PEI–p53 complexes inhibits B16-F10 lung metastases through regulation of angiogenesis , 2002, Cancer Gene Therapy.

[55]  G. Nicolson,et al.  Tumor cell and host properties affecting the implantation and survival of blood-borne metastatic variants of B16 melanoma. , 1978, Israel journal of medical sciences.